DBV Technologies delays VIASKIN Peanut Patch BLA submission to Q3 2026 after FDA feedback

DBV Technologies S.A.

BLA submission for VIASKIN Peanut Patch in children aged 4-7 delayed to Q3 2026.
FDA did not request additional data; feedback focused on CMC and biostatistical data formatting.
Company taking additional time to incorporate FDA input; prior timeline not specified.
Conference call scheduled June 29, 2026 at 5pm ET for investor update.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.